ED Coding & Reimbursement Alert - 2006 Issue 9
ICD-9 CODES: Prepare Now For Secondary Diabetes Codes
Subscribe or sign in to view the full article.
Article Overview
This article discusses a set of proposed ICD-9 diagnosis code changes that were being considered for a future update cycle. It is aimed at coders, CDI professionals, and billing teams tracking diagnosis code changes, especially where current reporting gaps or new distinctions are under review. The piece covers broad categories of proposed additions, including diabetes-related classification changes, medication use, endocrine conditions, neurologic conditions, infectious complications, and neoplasia-related updates.
Why This Topic Matters
Organizations that code diagnoses under ICD-9 needed to watch these proposals because they could affect documentation review, claim reporting, and future code selection workflows once implemented.
Article Sections
-
Proposed ICD-9 diagnosis code additions
An overview of the update cycle and the types of diagnosis areas being considered for new or revised ICD-9 classification. The section introduces the scope of the proposed changes and the committee process behind them.
-
Secondary diabetes
Discussion of the diabetes-related classification gap and the proposed creation of a separate category for diabetes associated with other underlying conditions.
-
Long-term drug use
Coverage of proposed additions related to ongoing medication exposure and the drug categories being considered for recognition in ICD-9.
-
Hypoaldosteronism
A brief look at the proposed endocrine-related code addition and how it fits into the existing ICD-9 structure.
-
Normal-pressure hydrocephalus
Discussion of a neurologic condition that is already indexed in ICD-9 but does not yet have its own code designation.
-
Wound botulism
Coverage of botulism types that are not currently represented in the same way as food-borne cases and are being considered for separate classification.
-
Neoplasia
Discussion of proposed coding changes involving selected neoplasia categories, including endocrine and vulvar intraepithelial neoplasia distinctions.
What You Will Learn
- Which broad diagnosis categories were being considered for ICD-9 changes
- How the article frames gaps in the existing ICD-9 diagnosis structure
- What kinds of proposed updates were under review by the committee
- Which specialties and clinical topics are affected by the proposed ICD-9 additions
Who Should Read This
- Medical coders
- Coding managers
- Compliance staff
- Clinical documentation improvement professionals
- Revenue cycle teams
- Healthcare administrators
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com